BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32590296)

  • 1. Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer.
    Mastelic-Gavillet B; Sarivalasis A; Lozano LE; Wyss T; Inoges S; de Vries IJM; Dartiguenave F; Jichlinski P; Derrè L; Coukos G; Melero I; Harari A; Romero P; Viganó S; Kandalaft LE
    Eur J Cancer; 2020 Aug; 135():173-182. PubMed ID: 32590296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased tubulointerstitial recruitment of human CD141(hi) CLEC9A(+) and CD1c(+) myeloid dendritic cell subsets in renal fibrosis and chronic kidney disease.
    Kassianos AJ; Wang X; Sampangi S; Muczynski K; Healy H; Wilkinson R
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1391-401. PubMed ID: 24049150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD141⁺ myeloid dendritic cells are enriched in healthy human liver.
    Kelly A; Fahey R; Fletcher JM; Keogh C; Carroll AG; Siddachari R; Geoghegan J; Hegarty JE; Ryan EJ; O'Farrelly C
    J Hepatol; 2014 Jan; 60(1):135-42. PubMed ID: 23968887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141
    Masterman KA; Haigh OL; Tullett KM; Leal-Rojas IM; Walpole C; Pearson FE; Cebon J; Schmidt C; O'Brien L; Rosendahl N; Daraj G; Caminschi I; Gschweng EH; Hollis RP; Kohn DB; Lahoud MH; Radford KJ
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32737142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human CD141
    Lee YS; O'Brien LJ; Walpole CM; Pearson FE; Leal-Rojas IM; Masterman KA; Atkinson V; Barbour A; Radford KJ
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FLT3-ligand treatment of humanized mice results in the generation of large numbers of CD141+ and CD1c+ dendritic cells in vivo.
    Ding Y; Wilkinson A; Idris A; Fancke B; O'Keeffe M; Khalil D; Ju X; Lahoud MH; Caminschi I; Shortman K; Rodwell R; Vuckovic S; Radford KJ
    J Immunol; 2014 Feb; 192(4):1982-9. PubMed ID: 24453245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.
    Jongbloed SL; Kassianos AJ; McDonald KJ; Clark GJ; Ju X; Angel CE; Chen CJ; Dunbar PR; Wadley RB; Jeet V; Vulink AJ; Hart DN; Radford KJ
    J Exp Med; 2010 Jun; 207(6):1247-60. PubMed ID: 20479116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Superior Ability of Human BDCA3
    Gu FF; Zhang K; Ma LL; Liu YY; Li C; Hu Y; Yang QF; Liang JY; Zeng YL; Wang Y; Liu L
    Front Immunol; 2020; 11():1267. PubMed ID: 32655564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Generation of Human XCR1(+) Dendritic Cells from CD34(+) Hematopoietic Progenitors.
    Balan S; Dalod M
    Methods Mol Biol; 2016; 1423():19-37. PubMed ID: 27142006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis.
    Cooles FAH; Anderson AE; Skelton A; Pratt AG; Kurowska-Stolarska MS; McInnes I; Hilkens CMU; Isaacs JD
    Front Immunol; 2018; 9():755. PubMed ID: 29867920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The In Vitro Differentiation of Human CD141+CLEC9A+ Dendritic Cells from Mobilized Peripheral Blood CD34+ Hematopoietic Stem Cells.
    Swartz AM; Nair SK
    Curr Protoc; 2022 Apr; 2(4):e410. PubMed ID: 35435334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy.
    Mastelic-Gavillet B; Sarivalasis A; Lozano LE; Lofek S; Wyss T; Melero I; de Vries IJM; Harari A; Romero P; Kandalaft LE; Viganó S
    Front Immunol; 2023; 14():1119371. PubMed ID: 36845155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute aerobic exercise induces a preferential mobilisation of plasmacytoid dendritic cells into the peripheral blood in man.
    Brown FF; Campbell JP; Wadley AJ; Fisher JP; Aldred S; Turner JE
    Physiol Behav; 2018 Oct; 194():191-198. PubMed ID: 29763678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness.
    Hémont C; Neel A; Heslan M; Braudeau C; Josien R
    J Leukoc Biol; 2013 Apr; 93(4):599-609. PubMed ID: 23341538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A
    Koster BD; López González M; van den Hout MF; Turksma AW; Sluijter BJ; Molenkamp BG; van Leeuwen PA; Vosslamber S; Scheper RJ; van den Eertwegh AJ; van den Tol MP; Jordanova EJ; de Gruijl TD
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fully closed and automated enrichment of primary blood dendritic cells for cancer immunotherapy.
    Schreibelt G; Duiveman-de Boer T; Pots JM; van Oorschot TGM; de Boer AJ; Scharenborg NM; van de Rakt MWMM; Bos K; de Goede AL; Petry K; Brüning M; Angerer C; Schöggl C; Dzionek A; de Vries IJM
    Methods Cell Biol; 2024; 183():33-50. PubMed ID: 38548417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLEC10A Is a Specific Marker for Human CD1c
    Heger L; Balk S; Lühr JJ; Heidkamp GF; Lehmann CHK; Hatscher L; Purbojo A; Hartmann A; Garcia-Martin F; Nishimura SI; Cesnjevar R; Nimmerjahn F; Dudziak D
    Front Immunol; 2018; 9():744. PubMed ID: 29755453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells.
    He M; Soni B; Schwalie PC; Hüsser T; Waltzinger C; De Silva D; Prinz Y; Krümpelmann L; Calabro S; Matos I; Trumpfheller C; Bacac M; Umaña P; Levesque MP; Dummer R; van den Broek M; Gasser S
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35688559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human CD141
    Pearson FE; Chang K; Minoda Y; Rojas IML; Haigh OL; Daraj G; Tullett KM; Radford KJ
    Immunol Cell Biol; 2018 Apr; 96(4):390-400. PubMed ID: 29344995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling.
    Makino K; Long MD; Kajihara R; Matsueda S; Oba T; Kanehira K; Liu S; Ito F
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35101945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.